These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26814712)

  • 1. High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma.
    Salem N; Kamal I; Al-Maghrabi J; Abuzenadah A; Peer-Zada AA; Qari Y; Al-Ahwal M; Al-Qahtani M; Buhmeida A
    Future Oncol; 2016 Feb; 12(3):323-31. PubMed ID: 26814712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma.
    Buhmeida A; Bendardaf R; Hilska M; Collan Y; Laato M; Syrjänen S; Syrjänen K; Pyrhönen S
    J Gastrointest Cancer; 2009; 40(3-4):91-7. PubMed ID: 19921474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.
    Yang B; Gao J; Rao Z; Shen Q
    Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer.
    Araújo RF; Lira GA; Vilaça JA; Guedes HG; Leitão MC; Lucena HF; Ramos CC
    Pathol Res Pract; 2015 Jan; 211(1):71-7. PubMed ID: 25446246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
    Bendardaf R; Buhmeida A; Hilska M; Laato M; Syrjänen S; Syrjänen K; Collan Y; Pyrhönen S
    Cancer Invest; 2010 Jan; 28(1):38-43. PubMed ID: 20001295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of MMP-9 over MMP-2 in HCC invasiveness and recurrence of hepatocellular carcinoma after curative resection.
    Chen R; Cui J; Xu C; Xue T; Guo K; Gao D; Liu Y; Ye S; Ren Z
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S375-84. PubMed ID: 21681378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
    Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
    Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S
    J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival stratification panel of colorectal carcinoma with combined expression of carcinoembryonic antigen, matrix metalloproteinases-2, and p27 kip1.
    Li M; Li JY; Zhao AL; He JS; Zhou LX; Li YA; Gu J
    Dis Colon Rectum; 2007 Nov; 50(11):1887-98. PubMed ID: 17882488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinase-9 (MMP-9) prognostic value in stage I colorectal carcinoma.
    Barresi V; Reggiani-Bonetti L; Di Gregorio C; Vitarelli E; Ponz De Leon M; Barresi G
    Pathol Res Pract; 2011 Aug; 207(8):479-86. PubMed ID: 21726963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and prognostic significance of human tissue kallikrein-related peptidase 6 (KLK6) in colorectal cancer.
    Petraki C; Dubinski W; Scorilas A; Saleh C; Pasic MD; Komborozos V; Khalil B; Gabril MY; Streutker C; Diamandis EP; Yousef GM
    Pathol Res Pract; 2012 Feb; 208(2):104-8. PubMed ID: 22285222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
    Wei QY; Wu YQ; Fan SQ
    Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelatinases A and B expression in human colorectal cancer in upper Egypt: a clinicopathological study.
    Omran OM; Thabet M
    Ultrastruct Pathol; 2012 Apr; 36(2):108-16. PubMed ID: 22471433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer.
    Yang B; Su K; Gao J; Rao Z
    Asian Pac J Cancer Prev; 2012; 13(3):1049-52. PubMed ID: 22631636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatinase B expression as a prognostic factor in patients with stage II/III rectal carcinoma treated by postoperative adjuvant therapy.
    Unsal D; Akyurek N; Uner A; Erpolat OP; Han U; Akmansu M; Mentes BB; Dursun A
    Am J Clin Oncol; 2008 Feb; 31(1):55-63. PubMed ID: 18376229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-9 is associated with relapse and prognosis of patients with colorectal cancer.
    Chu D; Zhao Z; Zhou Y; Li Y; Li J; Zheng J; Zhao Q; Wang W
    Ann Surg Oncol; 2012 Jan; 19(1):318-25. PubMed ID: 21455597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of matrix metalloproteinase-2 protein and matrix metalloproteinase-9 protein in colorectal cancer: a meta-analysis.
    Wang Y; Wei Y; Huang J; Li X; You D; Wang L; Ma X
    BMC Cancer; 2024 Aug; 24(1):1065. PubMed ID: 39210344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9.
    Zeng ZS; Huang Y; Cohen AM; Guillem JG
    J Clin Oncol; 1996 Dec; 14(12):3133-40. PubMed ID: 8955659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Expression of MMP-9 in Primary Tumors and High Preoperative MPO in Serum Predict Improved Prognosis in Colorectal Cancer with Operable Liver Metastases.
    Peltonen R; Hagström J; Tervahartiala T; Sorsa T; Haglund C; Isoniemi H
    Oncology; 2021; 99(3):144-160. PubMed ID: 33027796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.